KENNEDY CAPITAL MANAGEMENT LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 884589
ST LOUIS, MO
Position in XERS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,575,818
+$2,379,805 QoQ
Shares Held
1,209,068
-2.5% QoQ
Ownership
0.663%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#26
of 238 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $47,524,627 across 7 Drug Manufacturers - Specialty & Generic names. XERS ranks #2 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
295,938 | $24,497,747 | |
| 2 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
1,209,068 | $9,575,818 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
49,437 | $8,332,111 | |
| 4 | HROW |
Harrow, Inc.
|
70,748 | $3,004,667 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
48,387 | $837,578 | |
| 6 | VTRS |
Viatris Inc
|
43,906 | $697,227 | |
| 7 | ZTS |
Zoetis Inc.
|
8,064 | $579,479 |
All Filings in XERS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,575,818 | 1,209,068 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,196,013 | 1,240,692 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $9,529,656 | 1,213,969 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,862,285 | 1,211,583 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,811,406 | 816,147 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,035,627 | 735,087 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,258,062 | 666,095 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,723,842 | 604,857 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||